Deutsch Peter E. 13D and 13G filings for Spyre Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-23 2:10 pm Purchase | 2024-10-14 | 13G | Spyre Therapeutics, Inc. SYRE | Deutsch Peter E. | 3,550,276 6.990% | 3,550,276 (New Position) | Filing |